OREX

Orexigen Therapeutics, Inc. News Headlines

$6.33
*  
0.04
0.64%
Get OREX Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha


Arena And Vivus Investors Need To Grasp Implications Of Orexigen
12/19/2014 2:22:00 PM - Seeking Alpha


Contrave Wins Approval Recommendation In Europe
12/19/2014 11:53:00 AM - Seeking Alpha


Pre-Market Most Active for Dec 19, 2014 : ALLY, BBRY, BP, AVNR, TNK, PBR, OREX, BHP, SDRL, QQQ, AAPL, IMGN
12/19/2014 8:39:55 AM - NASDAQ.com News


Health Care Sector Update for 12/19/2014: CRME, TEVA, OREX
12/19/2014 8:36:09 AM - MT Newswires


Orexigen: Mysimba Receives Positive CHMP Opinion Recommending Approval In EU
12/19/2014 7:56:00 AM - RTT News


Six Biotech and Technology Stocks With Strong Technical Set-Ups
12/18/2014 1:44:00 PM - TheStreet


4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog
12/16/2014 11:26:00 AM - Investopedia


Low-Cost Contrave Fuels Anti-Obesity Drugs Recovery From Thanksgiving
12/16/2014 1:50:00 AM - Seeking Alpha


Why Should Investors Expect Physicians To Treat Obesity With Pharmacotherapy?
12/15/2014 10:30:00 AM - Seeking Alpha


Contrave Sales Continue To Impress
12/12/2014 4:26:00 PM - Seeking Alpha


Arena: Belviq Sales See Pleasant Rebound
12/12/2014 4:05:00 PM - Seeking Alpha


Assessing The Beginnings Of The Orexigen Launch Of Contrave
12/10/2014 1:09:00 PM - Seeking Alpha


Contrave Sales Are Driven By Reps And Discounts, Not Insurance (Yet)
12/9/2014 1:12:00 PM - Seeking Alpha


This Growing Concern Accounts For Nearly 500,000 Cancer Cases Each Year
12/7/2014 1:51:02 PM - Motley Fool


Will Diabetes Drugs Enter The Anti-Obesity Space?
12/7/2014 6:58:00 AM - Seeking Alpha


Orexigen Thera. To Present At Piper Jaffray Conference; Webcast At 12:30 PM ET
12/3/2014 11:30:00 AM - RTT News


Why Orexigen Therapeutics, Inc. Stock Rocketed 43% Higher in November
12/3/2014 8:36:03 AM - Motley Fool


Arena Pharmaceuticals: Belviq Sales Take A Modest Dip With Holiday
11/22/2014 2:51:00 PM - Seeking Alpha


Health Care Sector Update for 11/21/2014: OREX, MACK
11/21/2014 9:16:54 AM - MT Newswires


Janssen Is Working Its Way Toward Anti-Obesity
11/17/2014 5:14:00 PM - Seeking Alpha


EnteroMedics May Enter The Obesity Space - What Does It Mean?
11/17/2014 4:43:00 PM - Seeking Alpha


For This Obesity Drug, Europe Trumps the U.S.
11/17/2014 4:00:15 PM - Motley Fool


ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination
11/13/2014 9:52:00 AM - Seeking Alpha


Bel-Phen Pilot Study News, Hold On To Your Shares
11/11/2014 1:13:00 PM - Seeking Alpha